122 related articles for article (PubMed ID: 22020356)
1. A review and Bayesian meta-analysis of clinical efficacy and adverse effects of 4 atypical neuroleptic drugs compared with haloperidol and placebo.
Klemp M; Tvete IF; Skomedal T; Gaasemyr J; Natvig B; Aursnes I
J Clin Psychopharmacol; 2011 Dec; 31(6):698-704. PubMed ID: 22020356
[TBL] [Abstract][Full Text] [Related]
2. Aripiprazole: new drug. Just another neuroleptic.
Prescrire Int; 2005 Oct; 14(79):163-7. PubMed ID: 16285069
[TBL] [Abstract][Full Text] [Related]
3. Selection of atypical antipsychotics for the management of schizophrenia.
Sprague DA; Loewen PS; Raymond CB
Ann Pharmacother; 2004 Feb; 38(2):313-9. PubMed ID: 14742771
[TBL] [Abstract][Full Text] [Related]
4. Adverse effects of second-generation antipsychotics in children and adolescents: a Bayesian meta-analysis.
Cohen D; Bonnot O; Bodeau N; Consoli A; Laurent C
J Clin Psychopharmacol; 2012 Jun; 32(3):309-16. PubMed ID: 22544019
[TBL] [Abstract][Full Text] [Related]
5. Safety profile of iloperidone: a pooled analysis of 6-week acute-phase pivotal trials.
Weiden PJ; Cutler AJ; Polymeropoulos MH; Wolfgang CD
J Clin Psychopharmacol; 2008 Apr; 28(2 Suppl 1):S12-9. PubMed ID: 18334908
[TBL] [Abstract][Full Text] [Related]
6. Sertindole: new drug. Another "atypical" neuroleptic; QT prolongation.
Prescrire Int; 2007 Apr; 16(88):59-62. PubMed ID: 17458045
[TBL] [Abstract][Full Text] [Related]
7. Atypical antipsychotic drugs and diabetes mellitus in the US Food and Drug Administration Adverse Event database: a systematic Bayesian signal detection analysis.
Baker RA; Pikalov A; Tran QV; Kremenets T; Arani RB; Doraiswamy PM
Psychopharmacol Bull; 2009; 42(1):11-31. PubMed ID: 19204649
[TBL] [Abstract][Full Text] [Related]
8. [Antipsychotic Treatment of the Adult Patient in the Acute Phase of Schizophrenia].
Bohórquez Peñaranda A; Gómez Restrepo C; García Valencia J; Jaramillo González LE; de la Hoz AM; Arenas Á; Tamayo Martínez N
Rev Colomb Psiquiatr; 2014; 44 Suppl 1():13-28. PubMed ID: 26576459
[TBL] [Abstract][Full Text] [Related]
9. Weight effects associated with antipsychotics: a comprehensive database analysis.
Parsons B; Allison DB; Loebel A; Williams K; Giller E; Romano S; Siu C
Schizophr Res; 2009 May; 110(1-3):103-10. PubMed ID: 19321312
[TBL] [Abstract][Full Text] [Related]
10. The relationship of pharmacology to side effects.
Casey DE
J Clin Psychiatry; 1997; 58 Suppl 10():55-62. PubMed ID: 9265918
[TBL] [Abstract][Full Text] [Related]
11. Cell-mediated side effects of psychopharmacological treatment.
Maurer I; Volz HP
Arzneimittelforschung; 2001 Oct; 51(10):785-92. PubMed ID: 11715630
[TBL] [Abstract][Full Text] [Related]
12. Structural contributions of antipsychotic drugs to their therapeutic profiles and metabolic side effects.
Jafari S; Fernandez-Enright F; Huang XF
J Neurochem; 2012 Feb; 120(3):371-84. PubMed ID: 22103329
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of aripiprazole for the treatment of schizophrenia: an overview of systematic reviews.
Ribeiro ELA; de Mendonça Lima T; Vieira MEB; Storpirtis S; Aguiar PM
Eur J Clin Pharmacol; 2018 Oct; 74(10):1215-1233. PubMed ID: 29905899
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and tolerability of second-generation antipsychotics in children and adolescents with schizophrenia.
Kumra S; Oberstar JV; Sikich L; Findling RL; McClellan JM; Vinogradov S; Charles Schulz S
Schizophr Bull; 2008 Jan; 34(1):60-71. PubMed ID: 17923452
[TBL] [Abstract][Full Text] [Related]
15. Antipsychotic Drugs in Schizophrenia: Relative Effects in Patients With and Without Treatment Resistance.
Andrade C
J Clin Psychiatry; 2016 Dec; 77(12):e1656-e1660. PubMed ID: 28086018
[TBL] [Abstract][Full Text] [Related]
16. Adverse effects of antipsychotic agents. Do newer agents offer advantages?
Owens DG
Drugs; 1996 Jun; 51(6):895-930. PubMed ID: 8736614
[TBL] [Abstract][Full Text] [Related]
17. Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis.
Leucht S; Corves C; Arbter D; Engel RR; Li C; Davis JM
Lancet; 2009 Jan; 373(9657):31-41. PubMed ID: 19058842
[TBL] [Abstract][Full Text] [Related]
18. Low-dose clozapine pretreatment partially prevents haloperidol-induced deficits in conditioned active avoidance.
Murphy CA; Feldon J
Behav Pharmacol; 2000 Jun; 11(3-4):307-16. PubMed ID: 11103885
[TBL] [Abstract][Full Text] [Related]
19. Effects of antipsychotic treatment on psychopathology and motor symptoms. A placebo-controlled study in healthy volunteers.
Veselinović T; Schorn H; Vernaleken I; Schiffl K; Hiemke C; Zernig G; Gur R; Gründer G
Psychopharmacology (Berl); 2011 Dec; 218(4):733-48. PubMed ID: 21643673
[TBL] [Abstract][Full Text] [Related]
20. [The use of nifedipine as a corrector of extrapyramidal side-effects of classical neuroleptics].
Popov MIu
Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(6):28-33. PubMed ID: 18577931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
